The invention relates to quinazolinone compounds of the formula
wherein the R groups are defined in the specification, processes for their preparation and their use as pharmaceuticals, particularly in the treatment of disorders ameliorated by administration of TRPV1 antagonists.
本发明涉及公式中的
喹唑啉酮化合物,其中R基在规范中定义,其制备过程以及它们作为药物的用途,特别是在TRPV1
拮抗剂治疗改善的疾病中的应用。